Structural Heart Imaging Market Size, Key Companies, Trends, Segments, and Forecast 2026-2034

The global structural heart imaging market is projected to grow from USD 10.58 billion in 2026 to USD 16.76 billion by 2034, expanding at a CAGR of 5.91%. Growth is driven by the rising prevalence of congenital and lifestyle-related heart diseases, coupled with increasing adoption of minimally invasive procedures like TAVR.

Last Updated : 13 Oct 2026  |  Report Code : 5227  |  Format : PDF / PPT / Excel  |  Author : Deepa Pandey  |  Reviewed By : Aditi Shivarkar   |  ✓ Fact Checked   |  ❝ Cite Structural Heart Imaging Market Companies, Size & Trends 2026-2034
Source: https://www.precedenceresearch.com/structural-heart-imaging-market
Revenue, 2026
USD 10.58 Bn
Forecast Year, 2034
USD 16.76 Bn
CAGR, 2026 - 2035
5.91%
Report Coverage
Global

Structural Heart Imaging Market Size and Forecast 2026 to 2034

The global structural heart imaging market size was estimated at USD 10.58 billion in 2026 and is projected to reach approximately USD 16.76 billion by 2034, representing a CAGR of 5.91% from 2026 to 2034. The increasing incidence of various congenital diseases is the key factor driving the growth of the structural heart imaging market. Also, the rise in lifestyle-related diseases coupled with the growing prevalence of cardiac disorders can fuel market growth further.

Structural Heart Imaging Market Size 2025 to 2034

Structural Heart Imaging Market Key Takeaways

  • The global structural heart imaging market was valued at USD 10.58 billion in 2026.
  • It is projected to reach USD 16.76 billion by 2034.
  • The structural heart imaging market is expected to grow at a CAGR of 5.91% from 2026 to 2034.
  • North America led the structural heart imaging market with the largest market share of 36% in 2026.
  • Asia Pacific is expected to grow at a CAGR of 6.52% over the projected period.
  • By modality, the angiogram segment accounted for the biggest market share of 33% in 2026.
  • By modality, the computed tomography (CT) segment is anticipated to grow at the fastest CAGR of 8.12% over the forecast period.
  • By procedure, the transcatheter aortic valve replacement (TAVR) segment generated the biggest market share of 36% in 2026.
  • By procedure, the surgical aortic valve replacement (SAVR) segment is anticipated to grow at a significant CAGR of 6.1% during the forecast period.
  • By application, in 2026, the valvular heart disease segment held the largest share of the market. The congenital heart disease segment is projected to grow at the fastest rate in the market over the study period.
  • By end use, the hospital and clinics segment has held the largest market share of 55% in 2026, the ambulatory surgical centers segment is expected to show the fastest growth over the projected period.

Role of Artificial Intelligence in the Structural Heart Imaging Market

The application of Artificial Intelligence (AI) increasingly relies on robust data and appropriate computational tools in the structural heart imaging market. AI may decrease cost and enhance value at the stages of interpretation, image acquisition, and decision-making. Furthermore, AI-assisted cardiovascular imaging may support image acquisition, interpretation, procedural planning, and integration of imaging findings with electronic health records, depending on the application and clinical validation.

Market Overview

Structural heart imaging uses modalities such as echocardiography, CT, MRI, and angiography to assess the heart's structure, valves, chambers, and related blood vessels. Different imaging modalities use ultrasound, X-rays, magnetic fields, or other imaging technologies to produce views of cardiac anatomy and function. It is then used in assessing and enabling professionals while doing many operative procedures, including detecting blockages in the arteries.

Structural Heart Imaging Market Growth Factors

  • The increasing awareness about health and fitness among the majority of the population is the key factor boosting the structural heart imaging market growth.
  • The growing usage of transcatheter aortic valve replacement procedures is expected to propel market growth shortly.
  • The various initiatives undertaken by the governments of different countries will likely contribute to the market expansion further.

Market Dynamics

Driver

Increasing the use of the TAVR procedure

TAVR is a minimally invasive procedure used to replace a diseased aortic valve without conventional open-heart surgery. It's also becoming a crucial option for individuals at high risk of complications from open-heart surgery. In the structural heart imaging market, innovations in imaging technology, including 3D imaging and 4D imaging, real-time visualization, and virtual procedures, are commonly observed.

Restraint

Safety concerns

Safety concerns are a major challenge to the structural heart imaging market growth. Radiation exposure during fluoroscopy-guided procedures and CT imaging is an important safety consideration for patients and healthcare professionals. Exposure-reduction protocols and appropriate shielding are essential. Moreover, there is a lack of customized training for SHDIs, such as fellowships that emphasize procedural guidance and planning. Adoption of advanced structural heart devices may be constrained in some emerging economies by equipment costs, reimbursement limitations, infrastructure gaps, and shortages of trained specialists.

Opportunity

Improved accuracy and resolution

Enhanced accuracy and resolution in structural heart imaging are essential for various reasons. Improved resolution can offer high-quality, accurate diagnosis of heart conditions. Furthermore, precise imaging can help identify individuals at greater risk of complexities during or after the medical procedure. Additionally, imaging provides anatomical measurements that help clinicians plan procedures and guide device placement.

Segment Insights

Modality Insights

The angiogram segment dominated the structural heart imaging market in 2026. The dominance of the segment can be attributed to the improved devices, rise in research activities, and effective angiography techniques. Also, heavy funding from private and government organizations is prevalent.

The computed tomography (CT) segment is anticipated to grow at the fastest rate in the structural heart imaging market over the forecast period. The growth of the segment can be linked to the increase in the elderly population, rising demand to seek treatment efficiency, etc. Additionally, CT scanners are increasingly becoming common in medical settings, which helps in decreasing hospitalization times and enhancing disease treatment further.

Procedure Insights

The transcatheter aortic valve replacement (TAVR) segment led the global structural heart imaging market in 2026. The dominance of the segment can be linked to the increasing prevalence of high-risk heart disorders among individuals in the middle-aged population, which is a minimally invasive option as compared to conventional treatment. Because of the less invasive nature of this surgery, the rapid recovery of patients is possible.

The surgical aortic valve replacement (SAVR) segment is anticipated to grow at a significant rate in the structural heart imaging market during the forecast period. The growth of the segment can be driven by increasing aortic valve issues in the elderly population, enhanced valve designs, and the designing of advanced bio-compatible materials. Older age, left ventricular dysfunction, and chronic kidney disease can increase perioperative risk in patients undergoing surgical aortic valve replacement; individual risk depends on clinical status and other factors.

Application Insights

The valvular heart disease segment held the largest share of the structural heart imaging market. The dominance of the segment is due to the rising prevalence of diseases and infections such as blood infections, rheumatic fever, and high cholesterol among others. Untreated or severe valvular heart disease can lead to complications such as heart failure, arrhythmias, and, in some cases, life-threatening outcomes.

The congenital heart disease segment is projected to grow at the fastest rate in the structural heart imaging market over the study period. The growth of the segment can be credited to the rise in birth rates because this disease is associated with heart shape and heart structure by birth. Furthermore, CHDs can significantly affect the heart structure, causing blood to flow too slowly, abnormally, or not at all. Congenital heart disease is the most common type of birth defect, affecting nearly 1 in 100 babies.

End-use Insights

The hospital segment dominated the structural heart imaging market in 2026. This is due to the enhanced medical infrastructure of clinics and hospitals, innovative devices, and the availability of skilled medical professionals. Hospitals provide comprehensive treatment and care for various heart conditions. In addition, hospitals are well equipped with innovative diagnostic tools that aid in precise and timely diagnosis of heart disorders.

The ambulatory surgical centers segment is expected to show the fastest growth in the structural heart imaging market over the projected period. The growth of the segment can be driven by the easy availability of equipment, expanding infrastructure, and cost-effective surgery options provided by these centers. Furthermore, ambulatory surgical centers offer a more convenient, comfortable, and patient-oriented experience than outpatient settings in hospitals.

Regional Insights

North America Leads Structural Heart Imaging Adoption Through Advanced Cardiac Diagnostics and Medical Infrastructure

North America dominated the structural heart imaging market in 2026. The dominance of the region can be attributed to the rise in the number of patients suffering from cardiovascular diseases coupled with the heavy spending on medical infrastructure. Furthermore, the U.S. led the market in North America due to the high consumption of alcohol, which has led to an increasing prevalence of heart diseases among the majority population.

U.S. Structural Heart Imaging Market Size and Growth 2026 to 2034

The U.S. structural heart imaging market size was exhibited at USD 2.67 billion in 2026 and is projected to be worth around USD 4.31 billion by 2034, growing at a CAGR of 6.12% from 2026 to 2034.

U.S. Structural Heart Imaging Market Size 2025 to 2034

Asia Pacific Poised for Structural Heart Imaging Growth Through Rising Healthcare Spending and Cardiovascular Diagnostics

Asia Pacific is expected to grow at the fastest rate in the structural heart imaging market over the projected period. The growth of the region can be linked to the increase in expenditure on research for cardiovascular diseases and the rise in the older population in the region. Moreover, the high number of the population suffering from work-related stress along with the lack of physical activities are crucial factors contributing to market growth in the region.

Structural Heart Imaging Market Companies

Structural Heart Imaging Companies

  • GE Healthcare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V
  • Canon Medical System, USA
  • Boston Scientific Corporation
  • Medtronic
  • Edwards Lifesciences Corporation
  • Bracco
  • FUJIFILM Holdings Corporations
  • Hitachi, Ltd

Structural Heart Imaging Market Segments

By Modality

  • Echocardiogram
  • Angiogram
  • CT
  • MRI
  • Nuclear Imaging
  • Others

By Procedure

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Surgical Aortic Valve Replacement (SAVR)
  • Transcatheter Mitral Valve Repair (TMVR)
  • Left Atrial Appendage Closure (LAAC)
  • Annuloplasty
  • Valvuloplasty
  • Others

By Application

  • Valvular Heart Disease
  • Congenital Heart Disease

By End-use

  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The global structural heart imaging market size is expected to grow from USD 10.58 billion in 2026 to USD 16.76 billion by 2034.

Answer : The structural heart imaging market is anticipated to grow at a CAGR of 5.91% between 2026 and 2034.

Answer : The major players operating in the structural heart imaging market are GE Healthcare, Siemens Healthineers AG, Koninklijke Philips N.V, Canon Medical System, USA, Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, Bracco, FUJIFILM Holdings Corporations, Hitachi, Ltd, and Others.

Answer : The driving factors of the structural heart imaging market are the increasing incidence of various congenital diseases and rise in lifestyle-related diseases coupled with the growing prevalence of cardiac disorders.

Answer : North America region will lead the global structural heart imaging market during the forecast period 2026 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey

Deepa Pandey

Author

Deepa Pandey is the principal consultant in the precedence research, with 5+ years of experience in the market research industry.With a Master’s in Pharmacy specializing in Pharmaceutical Quality Assurance, Deepa Pandey brings a unique combination of scientific knowledge and market research expertise to Precedence Research. She plays a critical role in shaping the content and analysis that define the firm’s research reports. Over the past five years, Deepa has contributed to over 70 reports, providing clients with clear, actionable insights into the healthcare and pharmaceutical industries. Her deep understanding of regulatory requirements, quality processes, and operational dynamics allows her to translate complex information into practical strategies for global stakeholders.

Read more about Deepa Pandey
Aditi Shivarkar

Aditi Shivarkar LinkedIn

Reviewed By

Aditi brings more than 14 years of experience to Precedence Research, serving as the driving force behind the accuracy, clarity, and relevance of all research content. She reviews every piece of data and insight to ensure it meets the highest quality standards, supporting clients in making informed decisions. Her expertise spans healthcare, ICT, automotive, and diverse cross-industry domains, allowing her to provide nuanced perspectives on complex market trends. Aditi’s commitment to precision and analytical rigor makes her an indispensable leader in the research process.

Learn more about Aditi Shivarkar

Related Reports